London Jobs |
Manchester Jobs |
Liverpool Jobs |
Nottingham Jobs |
Birmingham Jobs |
Cambridge Jobs |
Glasgow Jobs |
Bristol Jobs |
Wales Jobs |
London Jobs |
Manchester Jobs |
Liverpool Jobs |
Nottingham Jobs |
Birmingham Jobs |
Cambridge Jobs |
Glasgow Jobs |
Bristol Jobs |
Wales Jobs |
Oil & Gas Jobs |
Banking Jobs |
Construction Jobs |
Top Management Jobs |
IT - Software Jobs |
Medical Healthcare Jobs |
Purchase / Logistics Jobs |
Sales |
Ajax Jobs |
Designing Jobs |
ASP .NET Jobs |
Java Jobs |
MySQL Jobs |
Sap hr Jobs |
Software Testing Jobs |
Html Jobs |
Job Location | Brentford |
Education | Not Mentioned |
Salary | Competitive salary |
Industry | Not Mentioned |
Functional Area | Not Mentioned |
Job Type | Permanent, full-time |
Site Name: UK - London - BrentfordPosted Date: Aug 20 2020ViiV HealthcareGlobal Health Outcomes Director, Pipeline & Patient Centered Outcomes Location: GSK House, Brentford, UKViiV healthcare is a pharmaceutical company focused exclusively on HIV, with the community central to everything that we do.As a company focused exclusively on HIV, ViiV Healthcare is embarking on a paradigm changing strategy to treat people living with HIV (PLWHIV). A progressive scientific platform has enabled ViiV Healthcare to build a pipeline of innovative therapies including 2 drug regimens, long acting (LA) injectables for both treatment and prevention, a drug in a completely new class for heavily treatment experienced patients, and a paediatric formulation, fulfilling the ViiV wider mission, to leave no person living with, or at risk of HIV left behind. Our innovative development pipeline includes molecules with new modes of action and methods of delivery, targeting 2DRs parenterally delivered.As part of the Research & Development and Global Medical Group (RDGM), the Global Health Outcomes (GHO) team is key in furthering the RDGM vision: Dedicated to delivering innovative HIV medicines, leaving no patients behind. GHO drives the demonstration of value for ViiV’s current and growing HIV portfolio, optimising patient benefit and access, with a growing focus on Patient Centred Outcomes (PCOs) and Real-World Evidence (RWE).Healthcare decision makers depend on manufacturers to generate evidence for new products to launch and maintain access. Lack of appropriate evidence to quantify the efficacy and safety of novel compounds and limitations in accessibility and usability of evidence (i.e. applicability of evidence supplied to the real-world) have been identified as barriers for informed healthcare decision making. Achieving and maintaining market access for a new product involves understanding the value evidence requirements for reimbursement and access, recognizing the challenges these pose for drug developers and identifying tactics to address these challenges.Role Purpose: